Werewolf Therapeutics (HOWL) Receivables - Net (2022 - 2024)

Werewolf Therapeutics (HOWL) has reported Receivables - Net for 3 consecutive years, with $500000.0 the latest figure, recorded in Q3 2024.

• On a quarterly basis, Receivables - Net fell 90.0% year-over-year to $500000.0 in Q3 2024; TTM through Sep 2024 was $500000.0, a 90.0% decrease from a year earlier, with the FY2023 full-year figure at $900000.0, down 67.86% from the prior year.
• Receivables - Net was $500000.0 for Q3 2024 at Werewolf Therapeutics, up from $300000.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $5.0 million in Q3 2023 and troughed at $300000.0 in Q2 2024.
• A 3-year average of $1.6 million and a median of $700000.0 in 2023 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net tumbled 67.86% in 2023 and plunged 90.0% in 2024, its largest moves.
• Over 3 years, Receivables - Net stood at $2.8 million in 2022, then plunged by 67.86% to $900000.0 in 2023, then sank by 44.44% to $500000.0 in 2024.
• The last three Receivables - Net figures came in at $500000.0 (Q3 2024), $300000.0 (Q2 2024), and $400000.0 (Q1 2024), per Business Quant data.